Novel diagnostic sensor for rapid and reproducible ro52 protein domain detection
AssigneeMeadowland Business Partners AB
InventorsOla Winqvist, Marie Wahren-Herlenius, Lars Baltzer
Life of this patent
Estimating the term…
Loading patent…
AssigneeMeadowland Business Partners AB
InventorsOla Winqvist, Marie Wahren-Herlenius, Lars Baltzer
Estimating the term…
The present invention relates to the use of specific synthetic sensor molecules for the discrimination of proteins and protein domains involved in autoimmunity. More specifically, in one embodiment, the invention relates to the detection of antibodies which bind to specific domains of the Ro52 protein. In another embodiment, the invention relates to the use of specific synthetic sensor molecules to identify domains of the Ro52 protein with different antibody specificities. The invention also includes a method for assessing the risk that a fetus will develop congenital heart block. The invention enables the evaluation and differential diagnosis of a range of autoimmune disorders, allowing appropriate treatment or more generally medical intervention decisions to be made.
A method for assessing a risk that a fetus will develop congenital heart block comprising screening a bodily fluid of a woman in need of screening for the presence of an antibody specifically recognizing Ro52 p200 peptide, the method comprising:
A method for detecting the presence of an antibody recognizing specifically Ro52 p200 peptide in a bodily fluid of a human comprising:
A method for assessing a risk that a fetus will develop congenital heart block comprising screening a bodily fluid of a woman in need of screening for the presence of an antibody specifically recognizing one or more Ro52 peptides, the method comprising:
Dependencies are inferred from the claim text.